A developed determination of midazolam and 1′-hydroxymidazolam in plasma by liquid chromatography–mass spectrometry: Application of human pharmacokinetic study for measurement of CYP3A activity

This publication has 31 references indexed in Scilit:

• A highly sensitive LC–MS–MS assay for analysis of midazolam and its major metabolite in human plasma: Applications to drug metabolism
  Journal of Chromatography B, 2005
• Determination of midazolam and its major metabolite 1′-hydroxymidazolam by high-performance liquid chromatography-electrospray mass spectrometry in plasma from children
  Journal of Chromatography B, 2005
• Sensitive determination of midazolam and 1′-hydroxymidazolam in plasma by liquid–liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity
  Journal of Chromatography B, 2004
• Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection
  Journal of Chromatography B, 2004
• Determination of picogram levels of midazolam, and 1- and 4-hydroxymidazolam in human plasma by gas chromatography–negative chemical ionization–mass spectrometry
  Journal of Chromatography B, 2004
• Determination of midazolam and 1′-hydroxymidazolam by liquid chromatography–mass spectrometry in plasma of patients undergoing methadone maintenance treatment
  Journal of Chromatography B, 2003
• CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism
  Annual Review of Pharmacology and Toxicology, 1999
• IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
  Annual Review of Pharmacology and Toxicology, 1998
• Determination of midazolam and its unconjugated 1-hydroxy metabolite in human plasma by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1995
• Determination of Midazolam and Its α-Hydroxy Metabolite in Human Plasma and Urine by High-Performance Liquid Chromatography
  Therapeutic Drug Monitoring, 1993